Breakthroughs Blog: Guest post
On International Women's Day, Medicines for Malaria Venture calls for sustained action to address biases, discrimination, and inequities that affect women and girls, including their access to malaria prevention and treatment.
A quick glance at the historical trajectory of malaria research reveals that it has been embedded in a larger context of gender bias in medical research. During the clinical development of most new medicines, including antimalarial drugs, pregnant people are actively excluded from trials. Fortunately, there is now growing determination within the malaria community to rectify gender-related data gaps.
An estimated 125 million pregnancies around the world are at risk from malaria annually. For both mother and baby, the disease is potentially life-threatening and babies that do survive are often born with low birth weight, which is associated with negative impact on development.